908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026)
908 Devices (MASS) reported Liabilities and Shareholders Equity of $186.7 million for Q1 2026, down 4.76% year-over-year from $196.0 million in Q1 2025, and down 1.78% quarter-over-quarter from $190.1 million in Q4 2025.
908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $186.7 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $186.7 million, down 4.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $759.3 million (up 2.26% YoY), and the FY2025 annual result was $190.1 million, up 19.18% from the prior year.
- Liabilities and Shareholders Equity retreated to $186.7 million in Q1 2026 per MASS's latest filing, from $190.1 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $251.2 million in Q1 2022 and troughed at $159.5 million in Q4 2024.
- A 5-year average of $207.2 million and a median of $203.0 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 49.9% in 2022, then retreated 21.43% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $242.6 million in 2022, then decreased by 16.33% to $203.0 million in 2023, then dropped by 21.43% to $159.5 million in 2024, then grew by 19.18% to $190.1 million in 2025, then retreated by 1.78% to $186.7 million in 2026.
- Business Quant data shows MASS's Liabilities and Shareholders Equity at $186.7 million in Q1 2026, $190.1 million in Q4 2025, and $190.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 6.63 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 10.74 Bn |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | 186.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.70 Mn |
| Dec 31, 2025 | 190.07 Mn |
| Sep 30, 2025 | 190.87 Mn |
| Jun 30, 2025 | 191.70 Mn |
| Mar 31, 2025 | 196.03 Mn |
| Dec 31, 2024 | 159.48 Mn |
| Sep 30, 2024 | 178.28 Mn |
| Jun 30, 2024 | 208.77 Mn |
| Mar 31, 2024 | 189.79 Mn |
| Dec 31, 2023 | 202.98 Mn |
| Sep 30, 2023 | 208.48 Mn |
| Jun 30, 2023 | 210.83 Mn |
| Mar 31, 2023 | 218.41 Mn |
| Dec 31, 2022 | 242.59 Mn |
| Sep 30, 2022 | 249.28 Mn |
| Jun 30, 2022 | 247.00 Mn |
| Mar 31, 2022 | 251.23 Mn |
| Dec 31, 2021 | 260.91 Mn |
| Sep 30, 2021 | 166.30 Mn |
| Jun 30, 2021 | 166.48 Mn |